We use cookies to provide you with a better experience. By continuing to browse the site you are agreeing to our use of cookies in accordance with our Cookie Policy.
Accept
Home » Sponsors Could Skirt Trial Requirements Under Senator’s ‘Progressive Approval’
Sponsors Could Skirt Trial Requirements Under Senator’s ‘Progressive Approval’
January 4, 2012
Draft proposals from Sen. Kay Hagan (D-N.C.) and the Biotechnology Industry Organization (BIO) would allow the FDA to grant marketing authorizations before sponsors meet current clinical trial requirements.